位置:首页 > 蛋白库 > FADH_ECOLI
FADH_ECOLI
ID   FADH_ECOLI              Reviewed;         672 AA.
AC   P42593; Q2M9C5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 180.
DE   RecName: Full=2,4-dienoyl-CoA reductase [(2E)-enoyl-CoA-producing] {ECO:0000303|PubMed:10933894, ECO:0000303|PubMed:9346310};
DE            Short=DCR {ECO:0000303|PubMed:12840019};
DE            EC=1.3.1.34 {ECO:0000269|PubMed:18171025, ECO:0000269|PubMed:6363415, ECO:0000269|PubMed:9346310};
DE   AltName: Full=2,4-dienoyl-coenzyme A reductase [NADPH] {ECO:0000305|PubMed:6363415};
GN   Name=fadH {ECO:0000303|PubMed:9346310}; Synonyms=ygjL;
GN   OrderedLocusNames=b3081, JW3052;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-31, FUNCTION,
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=K12;
RX   PubMed=9346310; DOI=10.1111/j.1432-1033.1997.00516.x;
RA   He X.-Y., Yang S.-Y., Schulz H.;
RT   "Cloning and expression of the fadH gene and characterization of the gene
RT   product 2,4-dienoyl coenzyme A reductase from Escherichia coli.";
RL   Eur. J. Biochem. 248:516-520(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR,
RP   ACTIVITY REGULATION, SUBUNIT, INDUCTION, AND PATHWAY.
RX   PubMed=6363415; DOI=10.1016/s0021-9258(17)43476-4;
RA   Dommes V., Kunau W.H.;
RT   "2,4-Dienoyl coenzyme A reductases from bovine liver and Escherichia coli.
RT   Comparison of properties.";
RL   J. Biol. Chem. 259:1781-1788(1984).
RN   [5]
RP   FUNCTION, COFACTOR, AND PATHWAY.
RC   STRAIN=K12;
RX   PubMed=10933894; DOI=10.1006/abbi.2000.1941;
RA   Liang X., Thorpe C., Schulz H.;
RT   "2,4-Dienoyl-CoA reductase from Escherichia coli is a novel iron-sulfur
RT   flavoprotein that functions in fatty acid beta-oxidation.";
RL   Arch. Biochem. Biophys. 380:373-379(2000).
RN   [6]
RP   CATALYTIC ACTIVITY, REACTION MECHANISM, ACTIVE SITE, AND MUTAGENESIS OF
RP   GLU-165; TYR-167; HIS-253 AND CYS-338.
RC   STRAIN=K12;
RX   PubMed=18171025; DOI=10.1021/bi701235t;
RA   Tu X., Hubbard P.A., Kim J.J., Schulz H.;
RT   "Two distinct proton donors at the active site of Escherichia coli 2,4-
RT   dienoyl-CoA reductase are responsible for the formation of different
RT   products.";
RL   Biochemistry 47:1167-1175(2008).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-672 IN COMPLEX WITH
RP   5-MERCAPTOETHANOL-2-DECENOYL-COENZYME A; FAD; FMN; IRON-SULFUR (4FE-4S) AND
RP   NADP, COFACTOR, DOMAIN, REACTION MECHANISM, AND ACTIVE SITE.
RC   STRAIN=K12;
RX   PubMed=12840019; DOI=10.1074/jbc.m304642200;
RA   Hubbard P.A., Liang X., Schulz H., Kim J.J.;
RT   "The crystal structure and reaction mechanism of Escherichia coli 2,4-
RT   dienoyl-CoA reductase.";
RL   J. Biol. Chem. 278:37553-37560(2003).
CC   -!- FUNCTION: Functions as an auxiliary enzyme in the beta-oxidation of
CC       unsaturated fatty acids with double bonds at even carbon positions.
CC       Catalyzes the NADPH-dependent reduction of the C4-C5 double bond of the
CC       acyl chain of 2,4-dienoyl-CoA to yield 2-trans-enoyl-CoA
CC       (PubMed:9346310, PubMed:6363415). Acts on both isomers, 2-trans,4-
CC       cis- and 2-trans,4-trans-decadienoyl-CoA, with almost equal efficiency
CC       (PubMed:6363415). Is not active with NADH instead of NADPH
CC       (PubMed:6363415). Does not show cis->trans isomerase activity
CC       (PubMed:10933894). {ECO:0000269|PubMed:10933894,
CC       ECO:0000269|PubMed:6363415, ECO:0000269|PubMed:9346310}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 4,5-saturated-(2E)-enoyl-CoA + NADP(+) = a (2E,4E)-dienoyl-
CC         CoA + H(+) + NADPH; Xref=Rhea:RHEA:12136, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:85100,
CC         ChEBI:CHEBI:85101; EC=1.3.1.34;
CC         Evidence={ECO:0000269|PubMed:18171025, ECO:0000269|PubMed:6363415,
CC         ECO:0000269|PubMed:9346310};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (2E,4Z)-dienoyl-CoA + H(+) + NADPH = a 4,5-saturated-(2E)-
CC         enoyl-CoA + NADP(+); Xref=Rhea:RHEA:45232, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:85099,
CC         ChEBI:CHEBI:85100; EC=1.3.1.34;
CC         Evidence={ECO:0000269|PubMed:6363415};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-decenoyl-CoA + NADP(+) = (2E,4E)-decadienoyl-CoA + H(+) +
CC         NADPH; Xref=Rhea:RHEA:53296, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:61406, ChEBI:CHEBI:62244;
CC         Evidence={ECO:0000269|PubMed:18171025, ECO:0000269|PubMed:6363415,
CC         ECO:0000269|PubMed:9346310};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-decenoyl-CoA + NADP(+) = (2E,4Z)-decadienoyl-CoA + H(+) +
CC         NADPH; Xref=Rhea:RHEA:53708, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:61406, ChEBI:CHEBI:137593;
CC         Evidence={ECO:0000269|PubMed:6363415};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:10933894, ECO:0000269|PubMed:12840019};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10933894, ECO:0000269|PubMed:12840019,
CC         ECO:0000269|PubMed:6363415};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000269|PubMed:10933894, ECO:0000269|PubMed:12840019};
CC   -!- ACTIVITY REGULATION: Is non-competitively inhibited by NADH.
CC       {ECO:0000269|PubMed:6363415}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=50 uM for NADPH {ECO:0000269|PubMed:9346310};
CC         KM=10.1 uM for NADPH {ECO:0000269|PubMed:6363415};
CC         KM=2.3 uM for (2E,4E)-decadienoyl-CoA {ECO:0000269|PubMed:9346310};
CC         KM=8.8 uM for (2E,4E)-decadienoyl-CoA {ECO:0000269|PubMed:6363415};
CC         KM=4.1 uM for (2E,4Z)-decadienoyl-CoA {ECO:0000269|PubMed:6363415};
CC         Note=kcat is 16 sec(-1) for the NADPH-reduction of (2E,4E)-
CC         decadienoyl-CoA. {ECO:0000269|PubMed:9346310};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC       {ECO:0000305|PubMed:10933894, ECO:0000305|PubMed:6363415}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:6363415}.
CC   -!- INTERACTION:
CC       P42593; P11349: narH; NbExp=3; IntAct=EBI-561933, EBI-555067;
CC       P42593; P19318: narY; NbExp=3; IntAct=EBI-561933, EBI-555059;
CC   -!- INDUCTION: Induced when cells are grown on oleate as sole carbon
CC       source. Repressed by glucose. {ECO:0000269|PubMed:6363415}.
CC   -!- DOMAIN: Is composed of three domains: an N-terminal TIM barrel
CC       (residues 1-368) which binds FMN, the 4Fe-4S cluster, and the
CC       substrate; a flavodoxin-like fold (residues 369-467 and 626-671) which
CC       binds FAD; and an NADP(H)-binding domain (residues 468-625).
CC       {ECO:0000269|PubMed:12840019}.
CC   -!- MISCELLANEOUS: The overall reaction mechanism can be divided into three
CC       stages: initially, reduction of FAD by NADPH, then electron transfer
CC       from FAD to FMN via the 4Fe-4S cluster, and finally reduction of
CC       substrate. {ECO:0000305|PubMed:12840019}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the NADH:flavin
CC       oxidoreductase/NADH oxidase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U93405; AAB82738.1; -; Genomic_DNA.
DR   EMBL; U18997; AAA57882.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76116.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77131.1; -; Genomic_DNA.
DR   PIR; F65096; F65096.
DR   RefSeq; NP_417552.1; NC_000913.3.
DR   RefSeq; WP_000121433.1; NZ_LN832404.1.
DR   PDB; 1PS9; X-ray; 2.20 A; A=2-672.
DR   PDBsum; 1PS9; -.
DR   AlphaFoldDB; P42593; -.
DR   SMR; P42593; -.
DR   BioGRID; 4261984; 17.
DR   BioGRID; 851910; 4.
DR   DIP; DIP-9562N; -.
DR   IntAct; P42593; 10.
DR   STRING; 511145.b3081; -.
DR   DrugBank; DB03698; 5-Mercaptoethanol-2-decenoyl-coenzyme A.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03247; Flavin mononucleotide.
DR   DrugBank; DB03461; Nicotinamide adenine dinucleotide phosphate.
DR   SwissLipids; SLP:000001817; -.
DR   jPOST; P42593; -.
DR   PaxDb; P42593; -.
DR   PRIDE; P42593; -.
DR   EnsemblBacteria; AAC76116; AAC76116; b3081.
DR   EnsemblBacteria; BAE77131; BAE77131; BAE77131.
DR   GeneID; 947594; -.
DR   KEGG; ecj:JW3052; -.
DR   KEGG; eco:b3081; -.
DR   PATRIC; fig|511145.12.peg.3176; -.
DR   EchoBASE; EB2582; -.
DR   eggNOG; COG0446; Bacteria.
DR   eggNOG; COG1902; Bacteria.
DR   HOGENOM; CLU_012153_1_1_6; -.
DR   InParanoid; P42593; -.
DR   OMA; QFLAAHT; -.
DR   PhylomeDB; P42593; -.
DR   BioCyc; EcoCyc:DIENOYLCOAREDUCT-MON; -.
DR   BioCyc; MetaCyc:DIENOYLCOAREDUCT-MON; -.
DR   BRENDA; 1.3.1.34; 2026.
DR   UniPathway; UPA00659; -.
DR   EvolutionaryTrace; P42593; -.
DR   PRO; PR:P42593; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IDA:EcoCyc.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:EcoCyc.
DR   GO; GO:0071949; F:FAD binding; IDA:EcoCyc.
DR   GO; GO:0010181; F:FMN binding; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033543; P:fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway; IMP:EcoCyc.
DR   Gene3D; 3.20.20.70; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR001155; OxRdtase_FMN_N.
DR   Pfam; PF00724; Oxidored_FMN; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Direct protein sequencing; FAD; Flavoprotein; FMN;
KW   Iron; Iron-sulfur; Metal-binding; NADP; Oxidoreductase; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:9346310"
FT   CHAIN           2..672
FT                   /note="2,4-dienoyl-CoA reductase [(2E)-enoyl-CoA-
FT                   producing]"
FT                   /id="PRO_0000194482"
FT   ACT_SITE        167
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0000305|PubMed:18171025"
FT   BINDING         25..27
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         59
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         101
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         176
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         215
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         253..256
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         289
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         311..312
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         335
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         338
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         340
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         340
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         342
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         354
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         385
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         404
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         412
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         422
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         449
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         563..564
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         567
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         578
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         649
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         654..656
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   BINDING         656..658
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:12840019,
FT                   ECO:0007744|PDB:1PS9"
FT   SITE            253
FT                   /note="Important for catalytic activity, assists active
FT                   site Tyr in protonation of C4"
FT                   /evidence="ECO:0000305|PubMed:12840019,
FT                   ECO:0000305|PubMed:18171025"
FT   MUTAGEN         165
FT                   /note="E->A: Exhibits 1.3% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         165
FT                   /note="E->Q: Loss of enzyme activity; when associated with
FT                   Ala-167."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         167
FT                   /note="Y->F: Forms 3-enoyl-CoA as the product of the
FT                   reaction instead of 2-enoyl-CoA, at a rate which is 26% of
FT                   wild-type. 2-fold increase in substrate affinity. Loss of
FT                   enzyme activity; when associated with Gln-165."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         253
FT                   /note="H->A: 1000-fold reduction in enzyme activity. Forms
FT                   both 3-enoyl-CoA and 2-enoyl-CoA as products of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         253
FT                   /note="H->F: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   MUTAGEN         338
FT                   /note="C->A: 1000-fold reduction in enzyme activity. Highly
FT                   affects iron-sulfur cluster binding."
FT                   /evidence="ECO:0000269|PubMed:18171025"
FT   TURN            4..7
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          16..23
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           36..49
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          53..64
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           78..80
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           81..93
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          98..102
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          115..119
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           134..153
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          157..163
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           168..173
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            175..177
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           188..206
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          208..219
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           228..241
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          244..250
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          259..261
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            266..269
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           270..276
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          284..286
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           293..301
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          306..311
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           313..316
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           320..325
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           329..331
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            340..342
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           343..347
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            358..361
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            363..365
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          376..380
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           384..394
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            395..397
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          399..409
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           413..416
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           425..439
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          442..446
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          451..454
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          457..462
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          466..468
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            475..477
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          481..483
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           484..488
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          496..501
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           504..514
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           521..523
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           525..531
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           541..543
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          555..561
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            568..571
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            574..576
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           577..586
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          590..592
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          596..601
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          604..609
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          612..616
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          619..623
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          627..629
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           634..638
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   TURN            639..641
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   STRAND          644..646
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           648..650
FT                   /evidence="ECO:0007829|PDB:1PS9"
FT   HELIX           658..671
FT                   /evidence="ECO:0007829|PDB:1PS9"
SQ   SEQUENCE   672 AA;  72678 MW;  B26C7CAAACE760C3 CRC64;
     MSYPSLFAPL DLGFTTLKNR VLMGSMHTGL EEYPDGAERL AAFYAERARH GVALIVSGGI
     APDLTGVGME GGAMLNDASQ IPHHRTITEA VHQEGGKIAL QILHTGRYSY QPHLVAPSAL
     QAPINRFVPH ELSHEEILQL IDNFARCAQL AREAGYDGVE VMGSEGYLIN EFLTLRTNQR
     SDQWGGDYRN RMRFAVEVVR AVRERVGNDF IIIYRLSMLD LVEDGGTFAE TVELAQAIEA
     AGATIINTGI GWHEARIPTI ATPVPRGAFS WVTRKLKGHV SLPLVTTNRI NDPQVADDIL
     SRGDADMVSM ARPFLADAEL LSKAQSGRAD EINTCIGCNQ ACLDQIFVGK VTSCLVNPRA
     CHETKMPILP AVQKKNLAVV GAGPAGLAFA INAAARGHQV TLFDAHSEIG GQFNIAKQIP
     GKEEFYETLR YYRRMIEVTG VTLKLNHTVT ADQLQAFDET ILASGIVPRT PPIDGIDHPK
     VLSYLDVLRD KAPVGNKVAI IGCGGIGFDT AMYLSQPGES TSQNIAGFCN EWGIDSSLQQ
     AGGLSPQGMQ IPRSPRQIVM LQRKASKPGQ GLGKTTGWIH RTTLLSRGVK MIPGVSYQKI
     DDDGLHVVIN GETQVLAVDN VVICAGQEPN RALAQPLIDS GKTVHLIGGC DVAMELDARR
     AIAQGTRLAL EI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024